GP Certificate of Benign & Precancerous Lesions Online

COURSE AIM  

This 12 week course will teach participants to distinguish a range of benign and precancerous lesions that are often identified by patients as skin lesions of concern and if required provide patients with a recommended treatment plan .  Engage directly with our expert Dermatologists via webinars and the discussion forum.  You will earn 40 RACGP points & 30 ACRRM points for this course.

COURSE STRUCTURE

Online Modules

This 12 week blended course consists of 5 online modules which cover the following topics:

1. Benign Epithelial Tumours
2. Benign Melanocytic Lesions
3. Benign Appendageal Tumours
4. Benign Tumours of the Dermis and Subcutaneous Fat
5. Premalignant or Precancerous Tumours

Live webinars

Attend live online webinars and participate in open discussion on diagnosis and management direct with our expert Dermatologists 

Topic Scenarios

Respond to authentic clinic case studies and challenge yourself to provide a diagnosis and first-step management plan on the clinical information and dermoscopic images

Assessment

Complete the scenarios, a 500 word case study and an online multiple choice final exam

COURSE FEES

GPs $1000
GP Registrars $900
Nurse Registrars & Other health professionals $900

ELIGIBILITY

This course is aimed at GPs and GP registrars.  Nurse practitioners and other medical registrars are also eligible.

Visit our website to see our full range of courses: https://www.dermcoll.edu.au/for-health-professionals/program-and-courses/

Register via External Site

03 Feb

Mon, 03 Feb 2020, at 6:00 AM to Sun, 03 May 2020, at 11:00 PM
Online Event
Starting from $900

RACGP

40 Category 1 Points

ACRRM

30 PRPD points


About ACD

The ACD is the peak medical college accredited by the Australian Medical Council for the training and professional development of medical practitioners in the specialty of dermatology. They provide authoritative information about dermatology to Government, the media, other health professionals and the general public.